他的捆绑节奏和左捆绑分支节奏在心力衰竭患者中
Patrycja Paluszkiewicz1, Adrian Martuszewski2, Jadwiga Radziejewska3
1Department of Emergency Medical Service, Wroclaw Medical University, ul. Parkowa 34, 51-616 Wrocław, Poland.
Biomedicines
|October 26, 2024
概括
他的捆绑节奏 (HBP) 和左捆绑分支节奏 (LBBP) 与传统节奏相比,为心力衰竭患者提供了改善的心脏功能和结果. 这些先进的技术可以在较少的并发症下恢复生理导电.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 他的捆绑节奏 (HBP) 和左捆支节奏 (LBBP) 是针对心力衰竭和导电障碍的新节奏策略.
- 这些技术旨在恢复自然的心脏导电,可能比传统方法改善心脏功能.
研究的目的:
- 评估HBP和LBBP的疗效和安全性.
- 将这些先进的节奏方法与心力衰竭和导电障碍患者的传统节奏方法进行比较.
主要方法:
- 对最近的研究和临床试验进行了全面的审查.
- 分析重点是心脏功能,QRS持续时间,患者结果,临床疗效,程序安全性和长期益处.
主要成果:
- 无论是HBP还是LBBP,心脏功能和临床结果都显著改善,而不是传统的节奏控制.
- HBP恢复了生理导电,减少了QRS持续时间;LBBP增强了左心室激活.
- 这两种技术都显示出更低的并发症率和更高的成功率在实现最佳节奏值.
结论:
- 对于特定的患者群体来说,HBP和LBBP代表了传统节奏的有希望的替代品.
- 这些先进的策略提供了优异的结果,改善了心脏功能,降低了风险.
- 需要进一步的研究来证实在不同人群中长期的益处和安全性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
527
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
527
Heart Failure Drugs: β-Blockers
320
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
320
Heart Failure II: Pathophysiology
1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Heart Failure IV: Classification and Diagnostic Evaluation
1
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1


